Hot Stock That Must Be in Your Portfolio: Ekso Bionics Holdings Inc. (NASDAQ: EKSO)

RICHMOND, Calif., November 19, 2019 – Shares of Ekso Bionics Holdings Inc. (NASDAQ: EKSO) gained 0.69% to $0.55. The stock traded total volume of 155.332K shares lower than the average volume of 493.47K shares.

Ekso Bionics Holdings, Inc. (EKSO) reported revenue of $3.30M for the quarter ended June 30, 2019 compared to $3.00M for the same period in 2018. Revenue in the second quarter of 2019 included approximately $2.80M in EksoHealth revenue compared to $2.40M in the same period in 2018, and $0.40M in EksoWorks sales compared to $0.60M in the same period in 2018. The Company booked 22 EksoGT units in the second quarter of 2019, including two rental units.

Gross profit for the quarter ended June 30, 2019 was $1.60M compared to $1.00M in the same period in 2018, representing a gross margin of approximately 48% compared to a gross margin for the same period in 2018 of 33%. The overall increase in gross margin is primarily due to higher average selling prices and lower production costs of the Company’s EksoGT devices.

Sales and marketing expenses for the quarter ended June 30, 2019 were $3.00M compared to $3.90M for the same period in 2018, a decrease of $0.90M or approximately 23%. The decrease was primarily due to lower general marketing and trade show expenses and a decrease in clinical trial activities as the Company nears completion of the WISE (Walking Improvement for spinal cord injury with Exoskeletons) study.

Research and development expenses for the quarter ended June 30, 2019 were $1.50M compared to $1.40M for the same period in 2018.

General and administrative expenses for the quarter ended June 30, 2019 were $2.10M compared to $2.80M for the same period in 2018, a decrease of $0.70M or approximately 25%. The decrease was primarily due to lower external consulting costs associated with business development related activities in China and lower legal expenses.

Net loss applicable to common stockholders for the quarter ended June 30, 2019 was $3.10M, or $0.04 per basic and diluted share, compared to $8.00M, or $0.13 per basic and diluted share, for the same period in 2018.

EKSO has the market capitalization of $41.28M. The return on assets ratio of the Company was -64.20% while its return on investment ratio stands at -351.00%. Price to sales ratio was 3.06 while 41.00% of the stock was owned by institutional investors.

Leave a Reply

Your email address will not be published. Required fields are marked *